AZ Groeninge is een supraregionaal ziekenhuis in de Belgische stad Kortrijk. Het ziekenhuis is het resultaat van een fusie van drie katholieke ziekenhuizen en één OCMW-ziekenhuis.

During the past decade, AZ Groeninge conducted 183 clinical trials. In the 10-year time frame, 183 clinical trials started and 71 clinical trials were completed, i.e. on average, 38.8% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 45 clinical trials were completed. i.e. 59.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Groeninge" #1 sponsor was "Hoffmann-La Roche" with 21 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 17 trials sponsored, "Pfizer" with 17 trials sponsored, "General Hospital Groeninge" with 13 trials sponsored and "Janssen Research & Development, LLC" with 13 trials sponsored. Other sponsors include 178 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Groeninge" #1 collaborator was "General Hospital Groeninge" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "Universitair Ziekenhuis Brussel" with 6 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials as a collaborator and "Astellas Pharma Inc" with 4 trials as a collaborator. Other collaborators include 171 different institutions and companies that were collaborators in the rest 137 trials.

According to Clinical.Site data, the most researched conditions in "AZ Groeninge" are "Prostate Cancer" (17 trials), "Breast Cancer" (13 trials), "Ulcerative Colitis" (10 trials), "Cancer" (8 trials) and "Colorectal Cancer" (8 trials). Many other conditions were trialed in "AZ Groeninge" in a lesser frequency.

Most popular intervention types in "AZ Groeninge" are "Drug" (185 trials), "Other" (24 trials), "Device" (23 trials), "Procedure" (21 trials) and "Biological" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (45 trials), "Lenalidomide" (8 trials), "Bevacizumab" (6 trials), "Nivolumab" (6 trials) and "Rituximab" (6 trials). Other intervention names were less common.

The vast majority of trials in "AZ Groeninge" are 209 trials for "All" genders, 31 trials for "Male" genders and 24 trials for "Female" genders.

Currently, there are NaN active trials in "AZ Groeninge". 1 are not yet recruiting, 54 are recruiting, 50 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 121 completed trials in AZ Groeninge, undefined suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Groeninge, 9 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 114 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 35 trials that are defined as “Not Applicable".

AZ Groeninge has several departments that took part in Clinical trials: "AZ Groeninge - Oncologisch Centrum" - 4 trials